Pacific Biosciences amends 2020 Equity Incentive Plan effective June 3, 2026
Pacific Biosciences filed an amended and restated 2020 Equity Incentive Plan with updates effective June 3, 2026, covering stock options, RSUs, and performance-based awards for employees, directors and consultants. The amendment reflects routine plan governance changes to maintain compliance with securities regulations and stock exchange requirements.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day